Cochrane Abstracts
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies. Accessed February 9, 2025.
First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies
First‐line Tandem High‐dose Chemotherapy and Autologous Stem Cell Transplantation Versus Single High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma, a Systematic Review of Controlled Studies [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
ID - 431910
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431910/all/First‐line_tandem_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_versus_single_high‐dose_chemotherapy_and_autologous_stem_cell_transplantation_in_multiple_myeloma__a_systematic_review_of_controlled_studies
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
